This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Heart Failure
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

Left ventricular assist devices (LVADs) are one treatment option for people with congestive heart failure. This study will evaluate the safety of injecting mesenchymal precursor cells (MPCs) into the heart during LVAD implantation surgery and examine if injecting MPCs into the heart is effective at improving heart function.

Provided treatments

  • Biological: Mesenchymal Precursor cells (RevascorTM)
  • Drug: Cryoprotective media alone
Tris trial is registered with FDA with number: NCT00927784. The sponsor of the trial is Icahn School of Medicine at Mount Sinai and it is looking for 10 volunteers for the current phase.
Official trial title:
The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Bridge to Transplant Patients